Concepedia

Scott D. Chasalow

SD

Statistics

Publications

30

Citations

3.8K

H-Index

24

Active since

1990

Affiliations

Bristol-Myers Squibb (United States)(Current)

Angeles Clinic and Research Institute

Dana-Farber Cancer Institute

Moffitt Cancer Center

Memorial Sloan Kettering Cancer Center

Scott D. Chasalow is an author at Bristol-Myers Squibb (United States) specializing in medicine, oncology, and cancer immunotherapy.

Publications per year

1990–2024

30

Publications

30

An immune-active tumor microenvironment favors clinical response to ipilimumab

Rui‐Ru Ji, Scott D. Chasalow, Lisu Wang et al. · Cancer Immunology Immunotherapy · 2011 · 777 citations · Full text

Medicine, Immunology, Oncology +10

A prospective phase II trial exploring the association between tumor microenvironment biomarkers and clinical activity of ipilimumab in advanced melanoma

Omid Hamid, Henrik Schmidt, Aviram Nissan et al. · Journal of Translational Medicine · 2011 · 531 citations · Full text

Medicine, Immunology, Oncology +17

EMT- and stroma-related gene expression and resistance to PD-1 blockade in urothelial cancer

Li Wang, Abdel Saci, Péter M. Szabó et al. · Nature Communications · 2018 · 331 citations · Full text

Medicine, Cancer Biology, Oncology +17

The Genetic Architecture of Response to Long-Term Artificial Selection for Oil Concentration in the Maize Kernel

Cathy C. Laurie, Scott D. Chasalow, John R. LeDeaux et al. · Genetics · 2004 · 313 citations · Full text

Life Sciences, Crop Sciences, Genetics +15

Immunomodulatory Activity of Nivolumab in Metastatic Renal Cell Carcinoma

Toni K. Choueiri, Mayer Fishman, Bernard Escudier et al. · Clinical Cancer Research · 2016 · 292 citations · Full text

Medicine, Immunology, Oncology +17

1–5 of 30